Medicamen Biotech (BOM:531146) Float Percentage Of Total Shares Outstanding: 0.00% (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531146 Medicamen Biotech Ltd BOM:531146
58 GF Score
Price ₹238.45
GF Value ₹510.73
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Medicamen Biotech Float Percentage Of Total Shares Outstanding?

Medicamen Biotech BOM:531146 +0.65% 58 Float Percentage Of Total Shares Outstanding is 0.00% as of Aug. 04, 2026. GuruFocus rates BOM:531146 with a GF Score™ of 58/100 and a GF Value™ of ₹510.73 (Possible Value Trap). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medicamen Biotech's float shares is 0.00 Mil. Medicamen Biotech's total shares outstanding is 13.56 Mil. Medicamen Biotech's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medicamen Biotech's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medicamen Biotech's Institutional Ownership is 0.00%.

BOM:531146
58GF Score
Medicamen Biotech Ltd BOM:531146
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicamen Biotech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Medicamen Biotech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/13.56
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Medicamen Biotech (BOM:531146) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Aug. 04, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Medicamen Biotech and its competitors.
Is Medicamen Biotech's Float Percentage Of Total Shares Outstanding too high?
Medicamen Biotech's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Medicamen Biotech has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medicamen Biotech's Float Percentage Of Total Shares Outstanding compare to ZTS?
Medicamen Biotech's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Medicamen Biotech and its competitors. Medicamen Biotech's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Biotech stock overvalued right now?
Based on GuruFocus' analysis, Medicamen Biotech (BOM:531146) is currently considered Possible Value Trap. The stock's GF Value™ is ₹510.73, compared to a current price of ₹238.45 — trading 53.3% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Medicamen Biotech's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Medicamen Biotech (BOM:531146), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicamen Biotech (BOM:531146) Overvalued in 2026?

Based on GuruFocus' analysis, Medicamen Biotech stock appears to be undervalued. The current stock price of ₹238.45 is trading 53.3% below its estimated GF Value™ of ₹510.73. GuruFocus considers Medicamen Biotech to be Possible Value Trap.

Key valuation signals for BOM:531146:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: ₹510.73 vs. price of ₹238.45 (53.3% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the BOM:531146 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicamen Biotech Business Description

Other Exchanges MEDICAMEQ:India
Address 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019
Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. It generates revenue from the sale of pharmaceutical products.
58GF Score

Get the complete analysis for BOM:531146

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹238.45
Price
₹510.73
GF Value